All In MedTech

Company

Glaukos

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Glaukos is on our public-company list (ticker GKOS). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

GKOS

NYSE · GLAUKOS Corp

Public float

$5.91B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$507M

Fiscal year ending Dec 31, 2025

Net income

-$188M

Fiscal year ending Dec 31, 2025

R&D spending

$151M

Fiscal year ending Dec 31, 2025

Cash

$162M

As of Sep 30, 2026

Long-term debt

Not reported

Shares outstanding

59.2M

As of Oct 26, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2024–––$53.2M

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jan 22, 2013Equity$30.0M$30.0M20Rule 506Form D ↗Jan 25, 2013
Oct 2, 2012Convertible note$6.0M$6.0M11Rule 506Form D ↗Oct 3, 2012
Aug 8, 2012Convertible note$4.5M$4.5M14Rule 506Form D ↗Aug 10, 2012

2 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
GLAUKOS Corp
Headquarters
Laguna Hills, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    9 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Glaukos we have 5 shareholders with 5% or more and 3 government grants totalling $300K.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    41 more trials with a free account

    Reports received

    121

    Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.

    Malfunction reports

    50

    41% of reports

    Injury reports

    70

    58% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 235600
    Jan 248700
    Feb 244400
    Mar 241400
    Apr 2421200
    May 2431400
    Jun 245800
    Jul 249500
    Aug 244700
    Sep 247700
    Oct 243800
    Nov 242900
    Dec 246900
    Jan 256700
    Feb 2561400
    Mar 254700
    Apr 253800
    May 251300
    Jun 252700
    Jul 254500
    Aug 255600
    Sep 252700
    Oct 2541300
    Nov 254700
    Dec 251700
    Jan 263700
    Feb 262400
    Mar 263400
    Apr 264800
    May 269900
    Jun 264500
    Jul 263400
    Aug 266401
    Sep 267500
    Oct 264600
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    6 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.